Trials from Edwards, Philips and Penumbra were among the most-watched studies at the annual cardiovascular meeting.
Some results have been hidden because they may be inaccessible to you
Show inaccessible resultsSome results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback